Tatjana Naranda
President & COO
Maxymune Therapeutics, Inc.
Joined February 2025BiotechnologyBiopharmaceuticals
Company
M
Maxymune Therapeutics, Inc.
Biotechnology
Founded2023
Investors8
Position
President & COO
Maxymune Therapeutics, Inc.
Document Signer
Responsibilities
- Oversees company operations
- Represents company in official filings
- Key decision maker
Notes
Location
Industry
Biotechnology
Biopharmaceuticals
Industry Metrics
Market Size$8.2B
YoY Growth12.8%
Companies483